EPISODE · Aug 24, 2016 · 21 MIN
Lessons from Autism on Accelerating Drug Development
from RARECast
The genomic revolution promises to unlock the underlying mechanism of many rare diseases and disorders, but progress in translating new discoveries into therapies that benefit patients can be frustratingly slow. We spoke to Robert Ring, former chief scientific officer of Autism Speaks, about innovative efforts he’s been involved with to overcome bottlenecks in translational medicine, advance research, and attract investment into drug development.
What this episode covers
The genomic revolution promises to unlock the underlying mechanism of many rare diseases and disorders, but progress in translating new discoveries into therapies that benefit patients can be frustratingly slow. We spoke to Robert Ring, former chief scientific officer of Autism Speaks, about innovative efforts he’s been involved with to overcome bottlenecks in translational medicine, advance research, and attract investment into drug development.
NOW PLAYING
Lessons from Autism on Accelerating Drug Development
No transcript for this episode yet
Similar Episodes
Feb 14, 2021 ·32m
Feb 13, 2021 ·98m
Sep 4, 2020 ·5m